Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?

被引:4
|
作者
Basalay, Maryna V. [1 ]
Davidson, Sean M. [1 ]
Yellon, Derek M. [1 ]
机构
[1] UCL, Hatter Cardiovasc Inst, London, England
关键词
D O I
10.4103/1673-5374.280313
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:1852 / 1853
页数:2
相关论文
共 50 条
  • [21] Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
    Luque, MA
    González, N
    Márquez, L
    Acitores, A
    Redondo, A
    Morales, M
    Valverde, I
    Villanueva-Peñacarrillo, ML
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 465 - 473
  • [22] STRUCTURE OF HUMAN GLP-1 (GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    REGULATORY PEPTIDES, 1992, 40 (02) : 223 - 223
  • [23] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
    Ja'arah, Daria
    Al Zoubi, Mazhar Salim
    Abdelhady, Gamal
    Rabi, Firas
    Tambuwala, Murtaza M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2021, 14
  • [24] Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)
    Ang, Richard
    Mastitskaya, Svetlana
    Hosford, Patrick S.
    Basalay, Marina
    Specterman, Mark
    Aziz, Qadeer
    Li, Yiwen
    Orini, Michele
    Taggart, Peter
    Lambiase, Pier D.
    Gourine, Andrey
    Tinker, Andrew
    Gourine, Alexander V.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (10): : e006740
  • [25] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
  • [26] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [27] Glucagon-like peptide-1, learning, and neuroprotection
    不详
    NEUROSCIENTIST, 2004, 10 (01): : 10 - 10
  • [28] Exaggerated secretion of glucagon-like peptide-1 (GLP-1) can explain reactive hypoglycaemia.
    ToftNielsen, M
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 1996, 39 : 594 - 594
  • [29] Exaggerated secretion of glucagon-like peptide-1 (GLP-1) can explain reactive hypoglycemia.
    ToftNielsen, M
    Madsbad, S
    Holst, JJ
    DIABETES, 1996, 45 : 858 - 858
  • [30] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19